ORIGINAL RESEARCH
Published on 07 Nov 2024
Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
doi 10.3389/fimmu.2024.1433119
- 1,139 views
449
Total downloads
2,010
Total views and downloads
Select the journal/section where you want your idea to be submitted:
Frontiers in Oncology
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Select the journal/section where you want your idea to be submitted: